The Question Is Whether To Buy Or Not To Buy Dyne Therapeutics Inc (NASDAQ: DYN)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Dyne Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Dyne Therapeutics Inc is $2.00B. A total of 1.5 million shares were traded on the day, compared to an average of 1.85M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, DYN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 10 BUYs and 33 SELLs from insiders. Insiders purchased 1,133,930 shares during that period but sold 470,622.

In the most recent transaction, Rhodes Jason P sold 196,928 shares of DYN for 22.70 per share on Feb 23. After the transaction, the Director now owns 920,843 company shares. In a previous transaction on Feb 23, Atlas Venture Fund XI, L.P. sold 159,542 shares at 22.70 per share. DYN shares that 10% Owner owns now total 6,352,562.

Among the insiders who sold shares, Atlas Venture Fund XI, L.P. disposed of 37,386 shares on Feb 23 at a per-share price of $22.70. This resulted in the 10% Owner holding 920,843 shares of DYN after the transaction. In another insider transaction, Atlas Venture Fund XI, L.P. sold 119,360 shares at $22.66 per share on Feb 22. Company shares held by the 10% Owner now total 6,512,104.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for DYN in the last 3 months, the mean price target is $34.67 with high estimates of $56.00 and low estimates of $20.00. In terms of 52-week highs and lows, DYN has a high of $25.50 and a low of $6.40.

As of this writing, DYN has an earnings estimate of -$0.92 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.73 per share and a lower estimate of -$1.08. The company reported an EPS of -$1.08 in the last quarter, which was -33.30% lower than expectations of -$0.81.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DYN’s latest balance sheet shows that the firm has $376.57M in Cash & Short Term Investments as of fiscal 2021. There were $32.64M in debt and $28.72M in liabilities at the time. Its Book Value Per Share was $2.48, while its Total Shareholder’s Equity was $368.20M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DYN is Buy with a score of 5.00.

Most Popular

Related Posts